Table 2 Future clinical implications of molecular genetic findings in fibromyalgia
From: Developments in the scientific and clinical understanding of fibromyalgia
Subgrouping of fibromyalgia patients |
Pharmacologic treatment based on knowledge of patient's genotype |
• Subjects with the short 5-HTTLPR allele may be more suitable candidates for antidepressant medication |
• Subjects without the 7DRD4 allele may be candidates for dopaminergic medication |